We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+15.25%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.49B
AUM Growth
+$561M
Cap. Flow
+$953M
Cap. Flow %
38.26%
Top 10 Hldgs %
19.27%
Holding
3,069
New
440
Increased
1,231
Reduced
593
Closed
189
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGX icon
776
Quest Diagnostics
DGX
$26.3B
$233K 0.01%
2,072
-36
-2% -$4.39K
OTIS icon
777
Otis Worldwide
OTIS
$28.2B
$233K 0.01%
3,460
+70
+2% +$4.54K
ARWR icon
778
Arrowhead Research
ARWR
$12.4B
$232K 0.01%
+3,694
New +$236K
ZBH icon
779
Zimmer Biomet
ZBH
$18.4B
$232K 0.01%
1,503
-453
-23% -$64K
NGG icon
780
National Grid
NGG
$81.3B
$231K 0.01%
4,408
-131
-3% -$6.95K
NJR icon
781
New Jersey Resources
NJR
$5.58B
$231K 0.01%
5,804
PTH icon
782
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$239M
$231K 0.01%
4,581
+3,891
+564% +$193K
TAP icon
783
Molson Coors Class B
TAP
$8.09B
$229K 0.01%
4,430
+2,592
+141% +$107K
TMUS icon
784
T-Mobile US
TMUS
$190B
$229K 0.01%
2,117
+639
+43% +$78.9K
BSJN
785
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
$229K 0.01%
9,092
+3,209
+55% +$80.3K
UCON icon
786
First Trust Smith Unconstrained Bond ETF
UCON
$3.28B
$227K 0.01%
8,565
-800
-9% -$21.2K
EZU icon
787
iShare MSCI Eurozone ETF
EZU
$9.91B
$226K 0.01%
4,872
-1,312
-21% -$54.1K
EW icon
788
Edwards Lifesciences
EW
$51.7B
$225K 0.01%
2,741
+682
+33% +$56.6K
UAL icon
789
United Airlines
UAL
$42.1B
$225K 0.01%
4,297
-669
-13% -$27.1K
SFHY
790
DELISTED
WisdomTree U.S. Short Term High Yield Corporate Bond Fund
SFHY
$225K 0.01%
4,549
+70
+2% +$3.4K
DRI icon
791
Darden Restaurants
DRI
$24.4B
$224K 0.01%
1,659
+150
+10% +$16.1K
DUSA icon
792
Davis Select US Equity ETF
DUSA
$1.27B
$224K 0.01%
6,811
+13
+0.2% +$359
SCHX icon
793
Schwab US Large- Cap ETF
SCHX
$74.5B
$223K 0.01%
20,094
+3,558
+22% +$50.9K
ZS icon
794
Zscaler
ZS
$27.3B
$223K 0.01%
1,421
-214
-13% -$34K
DBRG icon
795
DigitalBridge
DBRG
$2.95B
$222K 0.01%
8,810
+1,106
+14% +$17.7K
CQP icon
796
Cheniere Energy
CQP
$31.3B
$219K 0.01%
5,198
-537
-9% -$19.5K
CZR icon
797
Caesars Entertainment
CZR
$6.14B
$219K 0.01%
2,502
+124
+5% +$7.78K
UBSI icon
798
United Bankshares
UBSI
$6.62B
$218K 0.01%
6,863
+1,356
+25% +$38.3K
GOF icon
799
Guggenheim Strategic Opportunities Fund
GOF
$2.26B
$216K 0.01%
10,333
-8,543
-45% -$157K
CF icon
800
CF Industries
CF
$17.3B
$215K 0.01%
4,671
-1,542
-25% -$50.9K

Similar funds

Geneos Wealth Management's Q4 2020 Portfolio in Review

As of Q4 2020, Geneos Wealth Management held 3,069 positions worth $2.49B, up 29% from $1.93B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $953M of net new capital in Q4 2020, opening 440 new positions and adding to 1,231 existing holdings. Its largest new stake was ProShares Ultra Financials: 1,013,942 shares worth $53.6M.

By sector, the portfolio is most concentrated in Technology at 7.5% of assets, down from 7.9% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $19.8M trimmed.

  • Geneos Wealth Management's largest Q4 2020 buy was ProShares Ultra Financials: 1,013,942 shares worth $53.6M.
  • Geneos Wealth Management added most to State Street SPDR Portfolio S&P 500 ETF in Q4 2020, an estimated $45M increase.
  • Geneos Wealth Management's biggest Q4 2020 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $19.8M.
  • Geneos Wealth Management fully exited CrossFirst Bankshares, Inc. Common Stock in Q4 2020, selling an estimated $1.18M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $2.49B portfolio in Q4 2020.
  • Geneos Wealth Management opened 440 new positions and closed 189 in Q4 2020.
  • Geneos Wealth Management's portfolio value rose 29% quarter-over-quarter to $2.49B.

Based on Geneos Wealth Management's 13F filing for Q4 2020, filed 19 May 2021.